29th International Symposium on ALS/MND

This event is held after the one-day Allied Professionals Forum at the SEC in Glasgow on 6 December 2018. Each year, the Symposium attracts over 1,000 delegates, representing the energy and dynamism of the global MND research community. It is the largest medical and scientific conference specific to MND/ALS and is the premier event in the MND research calendar for discussion on the latest advances in research and clinical management.

The 29th International Symposium will take place in Glasgow, UK on 7-9 December 2018.

The Symposium is planned as two parallel meetings, one on biomedical research and the other on advances in the care and management of people affected by ALS/MND. Joint sessions consider issues of mutual concern, challenging current views and practices.

Research strand

• RNA processing and dysregulation
• Single cell biology
• Genetics and genomics
• Disease models
• Novel drug targets
• Axonal transport
• Protein stability and degradation
• Synaptic pathology
• Neuroinflammation

Clinical research and management strand

•  Comprehensive clinical evaluation
•  Assistive technology
•  Cognitive change
•  Respiratory management
•  End of life care
•  Clinical trials and trial design
•  Caregiver support
•  Surrogate markers
•  Nutrition and metabolism

Abstract submission system open: Mid-April 2018
Deadline for abstract submission: 6 June 2018